AlbuRx® 5, AlbuRx® 25 Albumin (Human) 5% Solution and 25% Solution AlbuRx® 5 is indicated for use in patients with shock, burns, pancreatitis and peritonitis, postoperative albumin loss, and hypoproteinemia with oncotic deficit. AlbuRx® 25 is indicated for use in patients with volume deficit/oncotic deficit. AlbuRx® 25 is usually appropriate in the following acute circumstances: shock and burns. AlbuRx® 25 may be appropriate in the following acute circumstances: adult respiratory distress syndrome (ARDS), cardiopulmonary bypass, pre- and postoperative hypoproteinemia, third space problems of infectious origin, acute liver failure, acute nephrosis, ascites, red cell resuspension media, renal dialysis, and hemolytic disease of the newborn.   While AlbuRx® 5 or 25 may be needed to treat acute complications of chronic hypoproteinemia, they are not indicated for treatment of the chronic condition itself. AlbuRx® is a solution containing the most abundant protein in human plasma, albumin, which is produced by the liver. Scientists first isolated albumin from plasma during World War II while researching a substitute for whole blood in the treatment of military casualties. AlbuRx® is used to expand the volume of fluid in the vascular compartment and to replace naturally occurring albumin in patients whose bodies do not have enough of the protein in the blood stream (hypoproteinemia). AlbuRx® is available in 5% and 25% solutions and is manufactured from U.S.-donor plasma in our state-of-the-art manufacturing facility in Bern, Switzerland. AlbuRx® 5 Albumin (Human) 5% Solution NDC Number           Product Description 44206-310-25              250 mL 44206-310-50              500 mL AlbuRx® 25 Albumin (Human) 25% Solution NDC Number           Product Description 44206-251-05              50 mL 44206-251-10              100 mL Important Safety Information The use of AlbuRx® 5 and 25 is contraindicated in patients with a history of an incompatibility reaction to albumin (human). In addition, AlbuRx® 5 may be contraindicated in patients with cardiac failure or severe anemia because of the risk of acute circulatory overload. Though very rare, non-septic incompatibility reactions including nausea, chills, fever, urticaria, headache, and hypotension following the administration of albumin-containing preparations have occasionally been observed. AlbuRx® is derived from human plasma. As with all plasma-derived products, the risk of transmission of infectious agents, including viruses and, theoretically, the Creutzfeldt-Jakob (CJD) disease agent, cannot be completely eliminated.  --------------------------------------------------------- 原产地英文药品名： Albumin Human 中文参考药品译名： 人血白蛋白 原产地英文商品名： AlbuRx5 5% 250mL Vial 中文参考商品译名： 瑞士安博灵 5%人血白蛋白 生产厂家英文名： Behring L.L.C., Bern, Switzerland 生产厂家中文参考译名： 瑞士Behring公司 --------------------------------------------------------------- 原产地英文药品名： Albumin Human 中文参考药品译名： 人血白蛋白 原产地英文商品名： AlbuRx5 5% 500mL Vial 中文参考商品译名： 瑞士安博灵 5%人血白蛋白 生产厂家英文名： Behring L.L.C., Bern, Switzerland 生产厂家中文参考译名： 瑞士Behring公司 -------------------------------------------------------------------- 原产地英文药品名： Albumin Human 中文参考药品译名： 人血白蛋白 原产地英文商品名： AlbuRx25 25% 50mL Vial 中文参考商品译名： 瑞士安博灵 25%人血白蛋白 生产厂家英文名： Behring L.L.C., Bern, Switzerland 生产厂家中文参考译名： 瑞士Behring公司 ------------------------------------------------------------------- 原产地英文药品名： Albumin Human 中文参考药品译名： 人血白蛋白 原产地英文商品名： AlbuRx25 25% 100mL Vial 中文参考商品译名： 瑞士安博灵 25%人血白蛋白 生产厂家英文名： Behring L.L.C., Bern, Switzerland 生产厂家中文参考译名： 瑞士Behring公司